These results are consistent with the results from the bioinformatics analysis of SMYD2 and show that ESCC, HCC, and breast cancer tumor samples and cell lines do indeed express SMYD2 at the protein level. Here, SMYD2 is linked to esophageal squamous cell carcinoma.